In the legend to Figure 3b, the labels for kinase-dead mutations and crizotinib-associated mutations were incorrect and should have read brown and yellow, respectively. This has now been corrected online.
Additional information
The online version of the original article can be found at 10.1038/nrc3580
Rights and permissions
About this article
Cite this article
Hallberg, B., Palmer, R. Erratum: Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology. Nat Rev Cancer 13, 820 (2013). https://doi.org/10.1038/nrc3614
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc3614
This article is cited by
-
EML4-ALK fusion protein in Lung cancer cells enhances venous thrombogenicity through the pERK1/2-AP-1-tissue factor axis
Journal of Thrombosis and Thrombolysis (2023)